Works matching AU Liu, Yunjiang


Results: 50
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 8769, doi. 10.1007/s00432-023-04817-9
    By:
    • Maimaitiaili, Amina;
    • Chen, Heyan;
    • Xie, Peiling;
    • Liu, Zhenzhen;
    • Ling, Rui;
    • Zhao, Yi;
    • Yang, Hongjian;
    • Liu, Yunjiang;
    • Liu, Ke;
    • Zhang, Jianguo;
    • Mao, Dahua;
    • Yu, Zhigang;
    • Liu, Yinhua;
    • Fu, Peifen;
    • Wang, Jiandong;
    • Jiang, Hongchuan;
    • Zhao, Zuowei;
    • Tian, Xingsong;
    • Cao, Zhongwei;
    • Wu, Kejin
    Publication type:
    Article
    17
    18

    Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 8, p. 673, doi. 10.1001/jama.2024.23560
    By:
    • Chen, Li;
    • Li, Hui;
    • Zhang, Hao;
    • Yang, Huawei;
    • Qian, Jun;
    • Li, Zhihua;
    • Ren, Yu;
    • Wang, Shu;
    • Fu, Peifen;
    • Yang, Hongjian;
    • Liu, Yunjiang;
    • Sun, Jing;
    • Nie, Jianyun;
    • Lei, Ruiwen;
    • Yao, Yongzhong;
    • Zhang, Anqin;
    • Wang, Shouman;
    • Ma, Xiaopeng;
    • Ouyang, Zhong;
    • Yang, Hongwei
    Publication type:
    Article
    19

    A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012).

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1326385
    By:
    • Maimaitiaili, Amina;
    • Yijun Li;
    • Na Chai;
    • Zhenzhen Liu;
    • Rui Ling;
    • Yi Zhao;
    • Hongjian Yang;
    • Yunjiang Liu;
    • Ke Liu;
    • Jianguo Zhang;
    • Dahua Mao;
    • Zhigang Yu;
    • Yinhua Liu;
    • Peifen Fu;
    • Jiandong Wang;
    • Hongchuan Jiang;
    • Zuowei Zhao;
    • Xingsong Tian;
    • Zhongwei Cao;
    • Kejin Wu
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012).

    Published in:
    Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156146
    By:
    • Chen, Heyan;
    • Maimaitiaili, Amina;
    • Liu, Zhenzhen;
    • Ling, Rui;
    • Zhao, Yi;
    • Yang, Hongjian;
    • Liu, Yunjiang;
    • Liu, Ke;
    • Zhang, Jianguo;
    • Mao, Dahua;
    • Yu, Zhigang;
    • Liu, Yinhua;
    • Fu, Peifen;
    • Wang, Jiandong;
    • Jiang, Hongchuan;
    • Zhao, Zuowei;
    • Tian, Xingsong;
    • Cao, Zhongwei;
    • Wu, Kejin;
    • Song, Ailin
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.606477
    By:
    • Xu, Ling;
    • Liu, Yinhua;
    • Fan, Zhimin;
    • Jiang, Zefei;
    • Liu, Yunjiang;
    • Ling, Rui;
    • Zhang, Jianguo;
    • Yu, Zhigang;
    • Jin, Feng;
    • Wang, Chuan;
    • Cui, Shude;
    • Wang, Shu;
    • Mao, Dahua;
    • Han, Bing;
    • Wang, Tao;
    • Zhang, Geng;
    • Wang, Ting;
    • Guo, Baoliang;
    • Yu, Lixiang;
    • Xu, Yingying
    Publication type:
    Article
    49
    50